logo-loader

Buds & Duds: Market conditions worsen for cannabis companies but Canntab Therapeutics soars on new joint venture agreement

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada sank 3.7% to 141.07 points. The OTCQX Cannabis Index slipped 2.6% to 515.3 points.

Buds today were Canntab Therapeutics Limited (CSE:PILL) (OTCMKTS:CTABF), Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP). The duds were MedMen Enterprises Inc (CSE:MMEN) (OTCMKTS:MMNFF), Aphria Inc (TSE:APHA). 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canntab Therapeutics Ltd named herein, including the promotion by the Company of Canntab Therapeutics Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks quiet into the weekend after milestone week in...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada fell 1.6% to 139.34 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 2.5% to C$10.77, while the OTCQX Cannabis Index sank 1.5% to...

9 hours, 50 minutes ago

2 min read